Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
World Vitiligo Map
Your guide to the vitiligo community worldwide. Use the selector to filter by patient support groups, specialists, research centers, clinical trial locations, or World Vitiligo Day events.
Directory Information & Disclaimer
This free public directory gathers information from public sources to help connect our global community. Medical professionals and organizations listed are independent and not affiliated with or endorsed by the Vitiligo Research Foundation (VRF), and no fees are accepted for listings.
Because clinics, support groups, and specialists move or update their services over time, some information may occasionally become outdated. As a result, VRF cannot guarantee the complete accuracy or usefulness of listed third-party resources.
Help Us Keep the Map Accurate
Do you need to add a listing, update outdated details, or request a removal? Please reach out to us using the feedback form on our Contact Us page.
Search Map
20 records found for “NCT07673640” · show all
- Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
Intervention: Drug: 1.5% Ruxolitinib Phosphate Cream (Opzelura); Drug: Corticosteroid Therapy
Status: Open now
Organizer: ShanShan Li
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-combined-with-corticosteroids-for-progressive-non-segmental-vitiligo-a-multicenter-real-world-studyShenzhen Hospital of Southern Medical University, Shenzhen, Guangdong, China
+86 18201346463
- Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
Intervention: Drug: 1.5% Ruxolitinib Phosphate Cream (Opzelura); Drug: Corticosteroid Therapy
Status: Open now
Organizer: ShanShan Li
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-combined-with-corticosteroids-for-progressive-non-segmental-vitiligo-a-multicenter-real-world-studyDongying People's Hospital, Dongying, Shandong, China
+86 18201346463
- Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
Intervention: Drug: 1.5% Ruxolitinib Phosphate Cream (Opzelura); Drug: Corticosteroid Therapy
Status: Open now
Organizer: ShanShan Li
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-combined-with-corticosteroids-for-progressive-non-segmental-vitiligo-a-multicenter-real-world-studyThe Second Hospital of Lanzhou University, Lanzhou, China
+86 18201346463
- Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
Intervention: Drug: 1.5% Ruxolitinib Phosphate Cream (Opzelura); Drug: Corticosteroid Therapy
Status: Open now
Organizer: ShanShan Li
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-combined-with-corticosteroids-for-progressive-non-segmental-vitiligo-a-multicenter-real-world-studyPeople's Hospital of Ningxia Hui Autonomous Region, Ningxiang, China
+86 18201346463
- Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
Intervention: Drug: 1.5% Ruxolitinib Phosphate Cream (Opzelura); Drug: Corticosteroid Therapy
Status: Open now
Organizer: ShanShan Li
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-combined-with-corticosteroids-for-progressive-non-segmental-vitiligo-a-multicenter-real-world-studyThe First Affiliated Hospital of Soochow University, Suzhou, China
+86 18201346463
- Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
Intervention: Drug: 1.5% Ruxolitinib Phosphate Cream (Opzelura); Drug: Corticosteroid Therapy
Status: Open now
Organizer: ShanShan Li
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-combined-with-corticosteroids-for-progressive-non-segmental-vitiligo-a-multicenter-real-world-studyChangzhi Second People's Hospital, Shangxi, China
+86 18201346463
- Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
Intervention: Drug: 1.5% Ruxolitinib Phosphate Cream (Opzelura); Drug: Corticosteroid Therapy
Status: Open now
Organizer: ShanShan Li
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-combined-with-corticosteroids-for-progressive-non-segmental-vitiligo-a-multicenter-real-world-studyShiyan People's Hospital (Hubei University of Medicine Affiliated People's Hospital), Shiyan, China
+86 18201346463
- Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
Intervention: Drug: 1.5% Ruxolitinib Phosphate Cream (Opzelura); Drug: Corticosteroid Therapy
Status: Open now
Organizer: ShanShan Li
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-combined-with-corticosteroids-for-progressive-non-segmental-vitiligo-a-multicenter-real-world-studyThe First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
+86 18201346463
- Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
Intervention: Drug: 1.5% Ruxolitinib Phosphate Cream (Opzelura); Drug: Corticosteroid Therapy
Status: Open now
Organizer: ShanShan Li
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-combined-with-corticosteroids-for-progressive-non-segmental-vitiligo-a-multicenter-real-world-studyThe Fourth Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
+86 18201346463
- Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
Intervention: Drug: 1.5% Ruxolitinib Phosphate Cream (Opzelura); Drug: Corticosteroid Therapy
Status: Open now
Organizer: ShanShan Li
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-combined-with-corticosteroids-for-progressive-non-segmental-vitiligo-a-multicenter-real-world-studyYueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
+86 18201346463
- Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
Intervention: Drug: 1.5% Ruxolitinib Phosphate Cream (Opzelura); Drug: Corticosteroid Therapy
Status: Open now
Organizer: ShanShan Li
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-combined-with-corticosteroids-for-progressive-non-segmental-vitiligo-a-multicenter-real-world-studyCentral Hospital of Jiaozuo Coal Industry (Group) Co., Ltd., Jiaozuo, China
+86 18201346463
- Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
Intervention: Drug: 1.5% Ruxolitinib Phosphate Cream (Opzelura); Drug: Corticosteroid Therapy
Status: Open now
Organizer: ShanShan Li
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-combined-with-corticosteroids-for-progressive-non-segmental-vitiligo-a-multicenter-real-world-studyThe Second People's Hospital of Huai'an, Huai'an, Jiangsu, China
+86 18201346463
- Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
Intervention: Drug: 1.5% Ruxolitinib Phosphate Cream (Opzelura); Drug: Corticosteroid Therapy
Status: Open now
Organizer: ShanShan Li
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-combined-with-corticosteroids-for-progressive-non-segmental-vitiligo-a-multicenter-real-world-studyXinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, China
+86 18201346463
- Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
Intervention: Drug: 1.5% Ruxolitinib Phosphate Cream (Opzelura); Drug: Corticosteroid Therapy
Status: Open now
Organizer: ShanShan Li
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-combined-with-corticosteroids-for-progressive-non-segmental-vitiligo-a-multicenter-real-world-studyChangzhou First People's Hospital, Changzhou, China
+86 18201346463
- Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
Intervention: Drug: 1.5% Ruxolitinib Phosphate Cream (Opzelura); Drug: Corticosteroid Therapy
Status: Open now
Organizer: ShanShan Li
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-combined-with-corticosteroids-for-progressive-non-segmental-vitiligo-a-multicenter-real-world-studyDongying People's Hospital, Dongying, China
+86 18201346463
- Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
Intervention: Drug: 1.5% Ruxolitinib Phosphate Cream (Opzelura); Drug: Corticosteroid Therapy
Status: Open now
Organizer: ShanShan Li
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-combined-with-corticosteroids-for-progressive-non-segmental-vitiligo-a-multicenter-real-world-studyAffiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
+86 18201346463
- Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
Intervention: Drug: 1.5% Ruxolitinib Phosphate Cream (Opzelura); Drug: Corticosteroid Therapy
Status: Open now
Organizer: ShanShan Li
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-combined-with-corticosteroids-for-progressive-non-segmental-vitiligo-a-multicenter-real-world-studyShenzhen Hospital, Southern Medical University, Shenzhen, China
+86 18201346463
- Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
Intervention: Drug: 1.5% Ruxolitinib Phosphate Cream (Opzelura); Drug: Corticosteroid Therapy
Status: Open now
Organizer: ShanShan Li
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-combined-with-corticosteroids-for-progressive-non-segmental-vitiligo-a-multicenter-real-world-studyNanjing Drum Tower Hospital, Nanjing, China
+86 18201346463
- Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
Intervention: Drug: 1.5% Ruxolitinib Phosphate Cream (Opzelura); Drug: Corticosteroid Therapy
Status: Open now
Organizer: ShanShan Li
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-combined-with-corticosteroids-for-progressive-non-segmental-vitiligo-a-multicenter-real-world-studyU-Family Clinic (Nanjing) Co., Ltd., Nanjing, China
+86 18201346463
- Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
Intervention: Drug: 1.5% Ruxolitinib Phosphate Cream (Opzelura); Drug: Corticosteroid Therapy
Status: Open now
Organizer: ShanShan Li
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-combined-with-corticosteroids-for-progressive-non-segmental-vitiligo-a-multicenter-real-world-studyThe First People's Hospital of Lianyungang, Lianyungang, China
+86 18201346463
FAQOther Questions
- How Vitiligo Changes with Age?
Vitiligo, a condition characterized by the loss of skin pigmentation, can affect individuals at any stage of life. While it often appears before the age of 20, its progression a...
- How to get insurance coverage for vitiligo treatments?
Getting insurance coverage for vitiligo treatments can be challenging, but there are several steps you can take to improve your chances For a more in-depth look, check out our u...
- Which therapy has minimal side-effects?
Dead Sea climatotherapy is a unique and highly effective treatment option for vitiligo, offering a top-tier safety profile and natural therapeutic benefits. Its combination of p...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.